altRx review

What it is

altRx is the trade name of Trinity HealthCare Supply, LLC, which provides the website and administration for an online weight-management membership. Medical care, including evaluation and prescribing, comes from OpenLoop Healthcare Partners, PC and its affiliated practices, and the site features three physicians: Dr. David Mansour, Dr. Ana Lisa Carr and Dr. Kelly Tenbrink. Prescriptions are filled by independent, state-licensed 503A compounding pharmacies, four of which it names with addresses: RedRock Pharmacy (St. George, Utah), Health Warehouse (Florence, Kentucky), Precision Medicine (Bellmore, New York) and Triad Rx (Daphne, Alabama). The company claims more than 125,000 patients. Its footer shows a LegitScript logo; if certification matters to you, confirm it on LegitScript's own website.

How it works

You complete a free two-minute assessment. A licensed provider in the OpenLoop network reviews it and holds a telehealth consultation, either by live video or as an asynchronous review, depending on your state's rules and the provider's judgment; a prescription is never guaranteed. If treatment is appropriate, the prescription goes to a pharmacy in the network, and processing and delivery take about four to five business days. Compounded semaglutide starts at 0.25 mg a week for four weeks and is raised toward 1 to 2.4 mg; compounded tirzepatide starts at 2.5 mg and rises by 2.5 mg every four weeks, up to 15 mg. Kits include syringes, needles and alcohol swabs. The membership includes unlimited check-ins and messaging and round-the-clock support by email or phone. You must be 18 or older. If your BMI falls below 25, your clinician will reassess and may move you to a maintenance dose or pause treatment, and if you stop, the provider may recommend a taper, because weight regain after stopping is common.

Pricing transparency

The site advertises compounded semaglutide at $89 a month and tirzepatide at $149, with shipping included, no membership fee and no increase as your dose rises. Those figures sit under a seasonal sale banner with an end date, which makes them a promotion rather than the standing price, and no regular price is published, so ask what the second month and later will cost before you pay. Its comparison table puts "other companies" at $179 and up. Brand-name drugs are listed at $1,579 a month for Wegovy, $1,249 for Zepbound and $1,149 for Ozempic. The refund policy is unusually strict: "all payments for the subscription services are final and non-refundable at the time of purchase", which applies even if you never finish your intake or never fill a prescription, and multi-month bundles can't be refunded in whole or in part. Cancel by email, phone or the patient portal at least 72 hours before your next billing date; a later request is charged for one more cycle. The only refund is for medical disqualification, and even then the value of any consultation or review already done is deducted. Insurance isn't required, and HSA and FSA cards are accepted.

Branded vs compounded

Compounded semaglutide and compounded tirzepatide by weekly injection from multi-dose vials, plus brand-name Wegovy, Zepbound and Ozempic. altRx's legal footer is accurate: the compounded drugs "are NOT FDA approved and have not been independently evaluated by the FDA for safety, efficacy, or quality", and the results it quotes come from members' self-reported weights and are "not derived from clinical trials". Its product pages are less careful. The semaglutide page says patients taking compounded GLP-1s lost an average of 12 to 15% of body weight over 68 weeks, which matches trials of branded semaglutide rather than any study of a compounded product, and lists "weight-loss outcomes supported by peer-reviewed clinical data" as a feature. The FDA's June 2026 warning letter objected to similar "clinically proven" claims and to product images that put the altRx name on the vial label, suggesting altRx compounds the drug when it doesn't; the letter is linked on this page. Ozempic is approved for type 2 diabetes, and the site correctly notes that using it for weight loss is off-label.

Pros and watch-outs

The evidence behind what altRx prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

• 503A vs 503B compounding pharmacies: what the difference actually buys you

  Both make drugs the FDA has never approved. Only one must meet CGMP, gets inspected on a schedule, and appears in a public table with its inspection outcomes.

How altRx compares

A few alternatives worth a look, depending on what you’re optimizing for.

• yourEra

  A low-cost entry point into compounded GLP-1 treatment

  See yourEra →
• Bodybuilding Health+

  GLP-1 alongside NAD⁺ and sermorelin from a fitness brand

  See Bodybuilding Health+ →
• Remedy Meds

  Buyers who want one compounded GLP-1 price at every dose, with video visits and labs included

  See Remedy Meds →

More GLP-1 telehealth reviews: Willow · Eden · WellMedRx · Sprout Health · Wellorithm · TrimRx